A homeopathic preparation diluted so far that no arsenic is expected to remain. Human evidence is thin and conflicting, most consistent with no effect beyond a dummy treatment. The real danger lies in poorly made products that still contain arsenic, which have caused serious liver injury, and in skipping proven care. (Full Review)

Protocol

Potency

30C

Sublingual pellets; higher potencies (200C, 1M) given less frequently by experienced prescribers

Prophylaxis dosing

Twice daily

For three to seven consecutive days, sometimes repeated periodically (COVID-19 program regimen)

Timing

Away from food

Away from strong flavors (coffee, mint) and brushing teeth — often on waking and at bedtime

Time to effect

Acute classical use

Minutes to hours

A correctly matched remedy is said to act this fast; any perceived benefit typically tracks the natural course of the illness

Prophylaxis

Not definable

No meaningful effect timeline can be defined because controlled evidence of a specific effect is lacking

Benefits

Speculative: Reduced COVID-19-like respiratory illness; prevention of post-vaccination fever; relief of anxiety, restlessness, and digestive upset; protection against arsenic-induced cellular damage

Contraindications

Pre-existing liver disease (cirrhosis, decompensated Child-Pugh B/C, NASH)

Chronic kidney disease (eGFR < 60, especially < 30 mL/min/1.73 m²)

Known elevated arsenic exposure (urinary inorganic arsenic above reference limit)

Pregnancy or breastfeeding (any trimester)

Young children (under 12 years, most acutely under 2)

Reliance on it for a serious, treatable condition

Key Interactions

Hepatotoxic drugs if arsenic present (acetaminophen, methotrexate, isoniazid)

QT-prolonging drugs if arsenic present (certain antiarrhythmics, macrolides such as azithromycin)

High-dose acetaminophen (OTC)

Use as a substitute for vaccination, antivirals, or conventional treatment

Risk & Side Effects

High: Arsenic poisoning from improperly diluted or adulterated products

Low: Delay or replacement of effective care

Speculative: Idiosyncratic or allergic reactions to excipients; "homeopathic aggravation"

Monitoring

Marker	Target	Why
ALT (alanine aminotransferase)	≤ 25 U/L (men), ≤ 22 U/L (women)	Detects liver-cell injury, the documented serious harm
AST (aspartate aminotransferase)	≤ 26 U/L	Confirms and contextualizes liver injury alongside ALT
Total bilirubin	0.3–1.0 mg/dL	Rising levels signal impaired liver clearance
eGFR (estimated glomerular filtration rate)	≥ 90 mL/min/1.73 m²	Kidney function governs arsenic excretion
Urinary total/speciated arsenic	Below laboratory detection	Direct check for residual arsenic exposure from the product

Cadence: Recheck liver enzymes and kidney function at roughly 4 weeks after starting, then every 3–6 months while use continues, with prompt unscheduled testing whenever symptoms suggesting toxicity appear. A single short course of a verified product generally needs only symptom-triggered testing.

Qualitative Assessment

Subjective anxiety and restlessness
Energy levels and fatigue
Digestive comfort
Sleep quality
Any new or warning symptoms (skin changes, numbness, jaundice) that signal possible toxicity rather than benefit

Arsenicum album for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment